These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 19944126)

  • 41. Development of acute inhalation reference exposure levels (RELs) to protect the public from predictable excursions of airborne toxicants.
    Collins JF; Alexeeff GV; Lewis DC; Dodge DE; Marty MA; Parker TR; Budroe JD; Lam RH; Lipsett MJ; Fowles JR; Das R
    J Appl Toxicol; 2004; 24(2):155-66. PubMed ID: 15052612
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health effects classification and its role in the derivation of minimal risk levels: immunological effects.
    Abadin HG; Chou CH; Llados FT
    Regul Toxicol Pharmacol; 2007 Apr; 47(3):249-56. PubMed ID: 17194513
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Study parameters influencing NOAEL and LOAEL in toxicity feeding studies for pesticides: exposure duration versus dose decrement, dose spacing, group size and chemical class.
    Zarn JA; Engeli BE; Schlatter JR
    Regul Toxicol Pharmacol; 2011 Nov; 61(2):243-50. PubMed ID: 21875639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A probabilistic effect assessment model for hazardous substances at the workplace.
    Schneider K; Schuhmacher-Wolz U; Hassauer M; Darschnik S; Elmshäuser E; Mosbach-Schulz O
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):172-81. PubMed ID: 16356615
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxicological resources for cumulative risk: an example with hazardous air pollutants.
    Fox MA; Tran NL; Groopman JD; Burke TA
    Regul Toxicol Pharmacol; 2004 Dec; 40(3):305-11. PubMed ID: 15546684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alternatives for a risk assessment on chronic noncancer effects from oral exposure to trichloroethylene.
    Barton HA; Das S
    Regul Toxicol Pharmacol; 1996 Dec; 24(3):269-85. PubMed ID: 8975757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Considerations and procedures in the derivation of ATSDR minimal risk levels.
    Wheeler JS; Chou S
    Vaccine; 2002 May; 20 Suppl 3():S51-5. PubMed ID: 12184367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing the risks of exposures to multiple chemicals with a common mechanism of toxicity: how to cumulate?
    Wilkinson CF; Christoph GR; Julien E; Kelley JM; Kronenberg J; McCarthy J; Reiss R
    Regul Toxicol Pharmacol; 2000 Feb; 31(1):30-43. PubMed ID: 10715222
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Approaches for evaluating the relevance of multiroute exposures in establishing guideline values for drinking water contaminants.
    Krishnan K; Carrier R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2008; 26(3):300-16. PubMed ID: 18781539
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Essentiality, toxicity, and uncertainty in the risk assessment of manganese.
    Boyes WK
    J Toxicol Environ Health A; 2010; 73(2):159-65. PubMed ID: 20077286
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interdisciplinary approach to assessing the health risk of air toxic chemicals: an overview.
    Grose EC; Selgrade MJ; Busnell PJ; Simmons JE; Allen J; McGee J; Hauchman F; Graham JA
    Toxicol Ind Health; 1990 Oct; 6(5):157-69. PubMed ID: 1670273
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determining acute health hazard ratings in the absence of applicable toxicological data.
    Simmons F; Quigley D; Freshwater D; Whyte H; Boada-Clista L; Laul JC
    J Occup Environ Hyg; 2007 Nov; 4(11):841-7. PubMed ID: 17885911
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hazardous substance releases at the community level: a practical approach to analyzing potential health threats.
    Neufer L; Narkunas D
    AAOHN J; 1994 Jul; 42(7):329-35. PubMed ID: 8060397
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of time extrapolation factors based on the database RepDose.
    Batke M; Escher S; Hoffmann-Doerr S; Melber C; Messinger H; Mangelsdorf I
    Toxicol Lett; 2011 Aug; 205(2):122-9. PubMed ID: 21640805
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Dermal Sensitisation Threshold- a TTC approach for allergic contact dermatitis.
    Safford RJ
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):195-200. PubMed ID: 18406502
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans.
    Williams GM; Kroes R; Munro IC
    Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):117-65. PubMed ID: 10854122
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Testing REACH draft technical guidance notes for conducting chemical safety assessments-the experience of a downstream user of a preparation.
    Gade AL; Ovrebø S; Hylland K
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):168-80. PubMed ID: 18479796
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Barium: rationale for a new oral reference dose.
    Dallas CE; Williams PL
    J Toxicol Environ Health B Crit Rev; 2001; 4(4):395-429. PubMed ID: 11695044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Uncertainty evaluation of human risk analysis (HRA) of chemicals by multiple exposure routes.
    Sassi G; Ruggeri B
    Risk Anal; 2008 Oct; 28(5):1343-56. PubMed ID: 18684163
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of exposure versus body burden data in deriving health guidance values.
    Pohl HR; Abadin HG; Jones DE; De Rosa CT
    J Toxicol Environ Health B Crit Rev; 2007; 10(6):401-15. PubMed ID: 17710608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.